United Therapeutics (UTHR) Research & Development (2016 - 2025)
Historic Research & Development for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $127.5 million.
- United Therapeutics' Research & Development rose 2318.84% to $127.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544.3 million, marking a year-over-year increase of 916.57%. This contributed to the annual value of $481.0 million for FY2024, which is 1789.22% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Research & Development is $127.5 million, which was up 2318.84% from $134.0 million recorded in Q2 2025.
- Over the past 5 years, United Therapeutics' Research & Development peaked at $303.7 million during Q1 2021, and registered a low of $66.1 million during Q3 2022.
- Over the past 5 years, United Therapeutics' median Research & Development value was $93.9 million (recorded in 2022), while the average stood at $113.8 million.
- In the last 5 years, United Therapeutics' Research & Development skyrocketed by 31489.07% in 2021 and then plummeted by 7728.02% in 2022.
- Quarter analysis of 5 years shows United Therapeutics' Research & Development stood at $82.9 million in 2021, then grew by 13.27% to $93.9 million in 2022, then surged by 61.24% to $151.4 million in 2023, then dropped by 11.62% to $133.8 million in 2024, then decreased by 4.71% to $127.5 million in 2025.
- Its last three reported values are $127.5 million in Q3 2025, $134.0 million for Q2 2025, and $149.0 million during Q1 2025.